Monopar Therapeutics Inc.

MNPR | NASDAQ

Price Alert Chart Builder DCF Calculator

$94.39

-$1.33 (-1.39%)

Sep 22, 2026, 1:29 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-13.72M	-15.59M	-8.4M	-10.52M	-9.1M	-6.3M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	4.84M	1.14M	1.9M	1.64M	1.47M	1.32M
Other Working Capital	-2.99M	2.99M	-20.41K	167.52K	-86.2K	-3.79K
Other Non-Cash Items	-716.46K	4.54M	n/a	n/a	n/a	-122.4K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-2.61M	3.5M	-1.35M	1.65M	317.77K	443.81K
Operating Cash Flow	-12.2M	-6.4M	-7.86M	-7.23M	-7.32M	-4.66M
Capital Expenditures	n/a	n/a	n/a	n/a	1	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-87.15M	-15.32M	-7.88M	-4.92M	n/a	n/a
Sales Maturities Of Investments	23.7M	985.73K	12.81M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-63.45M	-14.34M	4.93M	-4.92M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	122.4K
Common Stock Repurchased	-35M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.13M	-104.14K	-46.97K	-76.46K	-45.78K	-115.57K
Financial Cash Flow	91.57M	59.29M	2.03M	32.87K	10.88M	8.18M
Net Cash Flow	16.02M	38.55M	-920.11K	-12.12M	3.57M	3.52M
Free Cash Flow	-12.2M	-6.4M	-7.86M	-7.23M	-7.32M	-4.66M
Adj. Free Cash Flow	-17.04M	-7.54M	-9.76M	-8.87M	-8.79M	-5.98M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	1	n/a
Owner Earnings	-12.2M	-6.4M	-7.86M	-7.23M	-7.32M	-4.66M